Volume 107, Issue 4, Pages 954–960
Authors:
Angela S. Martin, M.D., Jeani Chang, M.P.H., Yujia Zhang, Ph.D., Jennifer F. Kawwass, M.D., Sheree L. Boulet, Dr.P.H., Patricia McKane, D.V.M., Dana Bernson, M.P.H., Dmitry M. Kissin, M.D., Denise J. Jamieson, M.D. for the States Monitoring Assisted Reproductive Technology (SMART) Collaborative
Abstract:
Compared with non-ART singletons, singletons born after eSET and non-eSET did not have increased risks whereas DET −1 and DET ≥2 singletons were more likely to have adverse perinatal outcomes.